|
|
| The SIRPα-CD47 immune checkpoint in NK cells. |
Deuse T, Hu X, Agbor-Enoh S, Jang MK, Alawi M, Saygi C, Gravina A, Tediashvili G, Nguyen VQ, Liu Y, Valantine H, Lanier LL, Schrepfer S.
J Exp Med. 2021 Mar 1;218(3):e20200839. doi: 10.1084/jem.20200839. |
|
|
| An Integrated Polygenic Tool Substantially Enhances Coronary Artery Disease Prediction. |
Riveros-Mckay F, Weale ME, Moore R, Selzam S, Krapohl E, Sivley RM, Tarran WA, Sørensen P, Lachapelle AS, Griffiths JA, Saffari A, Deanfield J, Spencer CCA, Hippisley-Cox J, Hunter DJ, O'Sullivan JW, Ashley EA, Plagnol V, Donnelly P.
Circ Genom Precis Med. 2021 Mar 2. doi: 10.1161/CIRCGEN.120.003304. |
|
|
| Validation of an Integrated Risk Tool, Including Polygenic Risk Score, for Atherosclerotic Cardiovascular Disease in Multiple Ethnicities and Ancestries. |
Weale ME, Riveros-Mckay F, Selzam S, Seth P, Moore R, Tarran WA, Gradovich E, Giner-Delgado C, Palmer D, Wells D, Saffari A, Sivley RM, Lachapelle AS, Wand H, Clarke SL, Knowles JW, O'Sullivan JW, Ashley EA, McVean G, Plagnol V, Donnelly P.
Am J Cardiol. 2021 Mar 3:S0002-9149(21)00207-1. doi: 10.1016/j.amjcard.2021.02.032. |
|
|
| Efficacy of a Centralized, Blended Electronic and Human Intervention to Improve Direct Oral Anticoagulant Adherence: Smartphones to improve rivaroxaban ADHEREnce in Atrial Fibrillation (SmartADHERE) A Randomized Clinical Trial: SmartADHERE rivaroxaban adherence trial. |
Turakhia M, Sundaram V, Smith SN, Ding V, Michael Ho P, Kowey PR, Piccini JP, Foody J, Birmingham M, Ianus J, Rajmane A, Mahaffey KW; smartADHERE Investigators.
Am Heart J. 2021 Mar 4:S0002-8703(21)00065-X. doi: 10.1016/j.ahj.2021.02.023. |
|
|
| Smart wearable devices in cardiovascular care: where we are and how to move forward. |
Bayoumy K, Gaber M, Elshafeey A, Mhaimeed O, Dineen EH, Marvel FA, Martin SS, Muse ED, Turakhia MP, Tarakji KG, Elshazly MB.
Nat Rev Cardiol. 2021 Mar 4:1-19. doi: 10.1038/s41569-021-00522-7. |
|
|
| Competing risks in patients with primary prevention implantable cardioverter-defibrillators: Global Electrical Heterogeneity and Clinical Outcomes (GEHCO) study. |
Waks JW, Haq KT, Tompkins C, Rogers AJ, Ehdaie A, Bender A, Minnier J, Dalouk K, Howell S, Peiris A, Raitt M, Narayan SM, Chugh SS, Tereshchenko LG.
Heart Rhythm. 2021 Mar 6:S1547-5271(21)00197-1. doi: 10.1016/j.hrthm.2021.03.006. |
|
|
| Kidney, Cardiovascular, and Safety Outcomes of Canagliflozin according to Baseline Albuminuria: A CREDENCE Secondary Analysis. |
Jardine M, Zhou Z, Lambers Heerspink HJ, Hockham C, Li Q, Agarwal R, Bakris GL, Cannon CP, Charytan DM, Greene T, Levin A, Li JW, Neuen BL, Neal B, Oh R, Oshima M, Pollock C, Wheeler DC, de Zeeuw D, Zhang H, Zinman B, Mahaffey KW, Perkovic V.
Clin J Am Soc Nephrol. 2021 Mar 8;16(3):384-395. doi: 10.2215/CJN.15260920. |
|
|
| Sex differences in congestive markers in patients hospitalized for acute heart failure. |
Espersen C, Campbell RT, Claggett B, Lewis EF, Groarke JD, Docherty KF, Lee MMY, Lindner M, Biering-Sørensen T, Solomon SD, McMurray JJV, Platz E.
ESC Heart Fail. 2021 Mar 11. doi: 10.1002/ehf2.13300. |
|
|
| Generation of three induced pluripotent stem cell lines, SCVIi003-A, SCVIi004-A, SCVIi005-A, from patients with ARVD/C caused by heterozygous mutations in the PKP2 gene. |
Jahng JWS, Black KE, Liu L, Bae HR, Perez M, Ashley EA, Sallam K, Wu JC.
Stem Cell Res. 2021 Mar 12;53:102284. doi: 10.1016/j.scr.2021.102284. |
|
|
| Worldwide Survey of COVID-19-Associated Arrhythmias. |
Coromilas EJ, Kochav S, Goldenthal I, Biviano A, Garan H, Goldbarg S, Kim JH, Yeo I, Tracy C, Ayanian S, Akar J, Singh A, Jain S, Zimerman L, Pimentel M, Osswald S, Twerenbold R, Schaerli N, Crotti L, Fabbri D, Parati G, Li Y, Atienza F, Zatarain E, Tse G, Leung KSK, Guevara-Valdivia ME, Rivera-Santiago CA, Soejima K, De Filippo P, Ferrari P, Malanchini G, Kanagaratnam P, Khawaja S, Mikhail GW, Scanavacca M, Abrahão Hajjar L, Rizerio B, Sacilotto L, Mollazadeh R, Eslami M, Laleh Far V, Mattioli AV, Boriani G, Migliore F, Cipriani A, Donato F, Compagnucci P, Casella M, Dello Russo A, Coromilas J, Aboyme A, O'Brien CG, Rodriguez F, Wang PJ, Naniwadekar A, Moey M, Kow CS, Cheah WK, Auricchio A, Conte G, Hwang J, Han S, Lazzerini PE, Franchi F, Santoro A, Capecchi PL, Joglar JA, Rosenblatt AG, Zardini M, Bricoli S, Bonura R, Echarte-Morales J, Benito-González T, Minguito-Carazo C, Fernández-Vázquez F, Wan EY.
Circ Arrhythm Electrophysiol. 2021 Mar;14(3):e009458. doi: 10.1161/CIRCEP.120.009458. |
|
|
| Electrical Substrate Ablation for Refractory Ventricular Fibrillation: Results of the AVATAR Study. |
Krummen DE, Ho G, Hoffmayer KS, Schweis FN, Baykaner T, Rogers AJ, Han FT, Hsu JC, Viswanathan MN, Wang PJ, Rappel WJ, Narayan SM.
Circ Arrhythm Electrophysiol. 2021 Mar;14(3):e008868. doi: 10.1161/CIRCEP.120.008868. |
|
|
| miR-106a-363 cluster in extracellular vesicles promotes endogenous myocardial repair via Notch3 pathway in ischemic heart injury. |
Jung JH, Ikeda G, Tada Y, von Bornstädt D, Santoso MR, Wahlquist C, Rhee S, Jeon YJ, Yu AC, O'brien CG, Red-Horse K, Appel EA, Mercola M, Woo J, Yang PC.
Basic Res Cardiol. 2021 Mar 19;116(1):19. doi: 10.1007/s00395-021-00858-8. |
|
|
| miR-132/212 Impairs Cardiomyocytes Contractility in the Failing Heart by Suppressing SERCA2a. |
Lei Z, Wahlquist C, El Azzouzi H, Deddens JC, Kuster D, van Mil A, Rojas-Munoz A, Huibers MM, Mercola M, de Weger R, Van der Velden J, Xiao J, Doevendans PA, Sluijter JPG.
Front Cardiovasc Med. 2021 Mar 19;8:592362. doi: 10.3389/fcvm.2021.592362. |
|
|
| CTA pulmonary artery enlargement in patients with severe aortic stenosis: Prognostic impact after TAVR. |
Turner VL, Jubran A, Kim JB, Maret E, Moneghetti KJ, Haddad F, Amsallem M, Codari M, Hinostroza V, Mastrodicasa D, Sailer AM, Kobayashi Y, Nishi T, Yeung AC, Watkins AC, Lee AM, Miller DC, Fischbein MP, Fearon WF, Willemink MJ, Fleischmann D.
J Cardiovasc Comput Tomogr. 2021 Mar 21:S1934-5925(21)00034-4. doi: 10.1016/j.jcct.2021.03.004. |
|
|
| Cell-Free DNA to Detect Heart Allograft Acute Rejection. |
Agbor-Enoh S, Shah P, Tunc I, Hsu S, Russell S, Feller E, Shah K, Rodrigo ME, Najjar SS, Kong H, Pirooznia M, Fideli U, Bikineyeva A, Marishta A, Bhatti K, Yang Y, Mutebi C, Yu K, Kyoo Jang M, Marboe C, Berry GJ, Valantine HA; GRAfT Investigators.
Circulation. 2021 Mar 23;143(12):1184-1197. doi: 10.1161/CIRCULATIONAHA.120.049098. |
|
|
| Functional and structural analysis of cytokine selective IL6ST defects that cause recessive hyper-IgE syndrome. |
Chen YH, Zastrow DB, Metcalfe RD, Gartner L, Krause F, Morton CJ, Marwaha S, Fresard L, Huang Y, Zhao C, McCormack C, Bick D, Worthey EA, Eng CM, Gold J; Undiagnosed Diseases Network, Montgomery SB, Fisher PG, Ashley EA, Wheeler MT, Parker MW, Shanmugasundaram V, Putoczki TL, Schmidt-Arras D, Laurence A, Bernstein JA, Griffin MDW, Uhlig HH.
J Allergy Clin Immunol. 2021 Mar 23:S0091-6749(21)00471-1. doi: 10.1016/j.jaci.2021.02.044. |
|
|
| Atrial Fibrillation Is Associated With Mortality in Intermediate Surgical Risk Patients With Severe Aortic Stenosis: Analyses From the PARTNER 2A and PARTNER S3i Trials. |
Brener MI, George I, Kosmidou I, Nazif T, Zhang Z, Dizon JM, Garan H, Malaisrie SC, Makkar R, Mack M, Szeto WY, Fearon WF, Thourani VH, Leon MB, Kodali S, Biviano AB.
J Am Heart Assoc. 2021 Mar 23:e019584. doi: 10.1161/JAHA.120.019584. |
|
|
| Genomic Context Differs Between Human Dilated Cardiomyopathy and Hypertrophic Cardiomyopathy. |
Puckelwartz MJ, Pesce LL, Dellefave-Castillo LM, Wheeler MT, Pottinger TD, Robinson AC, Kearns SD, Gacita AM, Schoppen ZJ, Pan W, Kim G, Wilcox JE, Anderson AS, Ashley EA, Day SM, Cappola T, Dorn GW 2nd, McNally EM.
J Am Heart Assoc. 2021 Mar 25:e019944. doi: 10.1161/JAHA.120.019944. |
|
|
| ALDH1A3 Coordinates Metabolism with Gene Regulation in Pulmonary Arterial Hypertension. |
Li D, Shao NY, Moonen JR, Zhao Z, Shi M, Otsuki S, Wang L, Nguyen T, Yan E, Marciano DP, Contrepois K, Li CG, Wu JC, Snyder MP, Rabinovitch M.
Circulation. 2021 Mar 25. doi: 10.1161/CIRCULATIONAHA.120.048845. |
|
|
| Clinical characteristics and outcomes in childhood-onset hypertrophic cardiomyopathy. |
Marston NA, Han L, Olivotto I, Day SM, Ashley EA, Michels M, Pereira AC, Ingles J, Semsarian C, Jacoby D, Colan SD, Rossano JW, Wittekind SG, Ware JS, Saberi S, Helms AS, Ho CY.
Eur Heart J. 2021 Mar 26:ehab148. doi: 10.1093/eurheartj/ehab148. |
|
|
| Emerging methods for the characterization of ischemic heart disease: ultrafast Doppler angiography, micro-CT, photon-counting CT, novel MRI and PET techniques, and artificial intelligence. |
Willemink MJ, Varga-Szemes A, Schoepf UJ, Codari M, Nieman K, Fleischmann D, Mastrodicasa D.
Eur Radiol Exp. 2021 Mar 25;5(1):12. doi: 10.1186/s41747-021-00207-3. |
|
|
| Effects of canagliflozin on cardiovascular, renal, and safety outcomes in participants with type 2 diabetes and chronic kidney disease according to history of heart failure: Results from the CREDENCE trial. |
Sarraju A, Li J, Cannon CP, Chang TI, Agarwal R, Bakris G, Charytan DM, de Zeeuw D, Greene T, Heerspink HJL, Levin A, Neal B, Pollock C, Wheeler DC, Yavin Y, Zhang H, Zinman B, Perkovic V, Jardine M, Mahaffey KW.
Am Heart J. 2021 Mar;233:141-148. doi: 10.1016/j.ahj.2020.12.008. |
|
|
| The Effects of Canagliflozin on Heart Failure and Cardiovascular Death by Baseline Participant Characteristics: Analysis of the CREDENCE Trial. |
Arnott C, Li JW, Cannon CP, de Zeeuw D, Neuen BL, Heerspink HJL, Charytan DM, Agarwal A, Huffman MD, Figtree GA, Bakris G, Chang TI, Feng K, Rosenthal N, Zinman B, Jardine MJ, Perkovic V, Neal B, Mahaffey KW.
Diabetes Obes Metab. 2021 Mar 26. doi: 10.1111/dom.14386. |
|
|
| 2021 ISHNE/ HRS/ EHRA/ APHRS collaborative statement on mHealth in Arrhythmia Management: Digital Medical Tools for Heart Rhythm Professionals: From the International Society for Holter and Noninvasive Electrocardiology/Heart Rhythm Society/European Heart Rhythm Association/Asia Pacific Heart Rhythm Society. |
Varma N, Cygankiewicz I, Turakhia M, Heidbuchel H, Hu Y, Chen LY, Couderc JP, Cronin EM, Estep JD, Grieten L, Lane DA, Mehra R, Page A, Passman R, Piccini J, Piotrowicz E, Piotrowicz R, Platonov PG, Ribeiro AL, Rich RE, Russo AM, Slotwiner D, Steinberg JS, Svennberg E.
Ann Noninvasive Electrocardiol. 2021 Mar;26(2):e12795. doi: 10.1111/anec.12795. |
|
|
| Computational prediction of protein subdomain stability in MYBPC3 enables clinical risk stratification in hypertrophic cardiomyopathy and enhances variant interpretation. |
Thompson AD, Helms AS, Kannan A, Yob J, Lakdawala NK, Wittekind SG, Pereira AC, Jacoby DL, Colan SD, Ashley EA, Saberi S, Ware JS, Ingles J, Semsarian C, Michels M, Mazzarotto F, Olivotto I, Ho CY, Day SM.
Genet Med. 2021 Mar 29. doi: 10.1038/s41436-021-01134-9. |
|
|
| Myocarditis Surveillance with High-Sensitivity Troponin I During Cancer Treatment with Immune Checkpoint Inhibitors. |
Waliany S, Neal JW, Reddy S, Wakelee H, Shah SA, Srinivas S, Padda SK, Fan AC, Colevas AD, Wu SM, Witteles RM, Zhu H.
JACC CardioOncol. 2021 Mar;3(1):137-139. doi: 10.1016/j.jaccao.2021.01.004. |
|
|
| Diagnostic Cardiovascular Magnetic Resonance Imaging Criteria in Noncompaction Cardiomyopathy and the Yield of Genetic Testing. |
van Waning JI, Caliskan K, Chelu RG, van der Velde N, Pezzato A, Michels M, van Slegtenhorst MA, Boersma E, Nieman K, Majoor-Krakauer D, Hirsch A.
Can J Cardiol. 2021 Mar;37(3):433-442. doi: 10.1016/j.cjca.2020.05.021. |
|
|
| Identification of rare and common regulatory variants in pluripotent cells using population-scale transcriptomics. |
Bonder MJ, Smail C, Gloudemans MJ, Frésard L, Jakubosky D, D'Antonio M, Li X, Ferraro NM, Carcamo-Orive I, Mirauta B, Seaton DD, Cai N, Vakili D, Horta D, Zhao C, Zastrow DB, Bonner DE; HipSci Consortium; iPSCORE consortium; Undiagnosed Diseases Network; PhLiPS consortium, Wheeler MT, Kilpinen H, Knowles JW, Smith EN, Frazer KA, Montgomery SB, Stegle O.
Nat Genet. 2021 Mar;53(3):313-321. doi: 10.1038/s41588-021-00800-7. |
|
|
| Development of a Cost Measure for Screening/Surveillance Colonoscopy for the Merit-Based Incentive Payment System. |
Park WG, Sandhu A, MaCurdy T; collaborators of the Clinical Subcommittee for Screening/Surveillance Colonoscopy , Unlisted Authors to be included when searched in PubMed, Choradia N, Schmitt C, Koscheski C, Lam J, Bounds S, Do R, Feinberg L, Vail D, Nagavarapu S, Bhattacharya J.
Gastroenterology. 2021 Mar 30:S0016-5085(21)00550-3. doi: 10.1053/j.gastro.2021.03.040. |
|
|
| Women's Health Initiative Strong and Healthy Pragmatic Physical Activity Intervention Trial for Cardiovascular Disease Prevention: Design and Baseline Characteristics. |
Stefanick ML, King AC, Mackey S, Tinker LF, Hlatky MA, LaMonte MJ, Bellettiere J, Larson JC, Anderson G, Kooperberg CL, LaCroix AZ.
J Gerontol A Biol Sci Med Sci. 2021 Mar 31;76(4):725-734. doi: 10.1093/gerona/glaa325. |
|
|
| Dosing of Direct Oral Anticoagulants in Patients with Moderate Chronic Kidney Disease in US Clinical Practice: Results from the Outcomes Registry for Better Informed Treatment of AF (ORBIT-AF II). |
Jackson LR 2nd, Schrader P, Thomas L, Steinberg BA, Blanco R, Allen LA, Fonarow GC, Freeman JV, Gersh BJ, Kowey PR, Mahaffey KW, Naccarelli G, Reiffel J, Singer DE, Peterson ED, Piccini JP; Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) II Investigators and Patients.
Am J Cardiovasc Drugs. 2021 Mar 31. doi: 10.1007/s40256-021-00473-x. |
|
|
| The clinical utility of FFRCT stratified by age. |
Anastasius M, Maggiore P, Huang A, Blanke P, Patel MR, Nørgaard BL, Fairbairn TA, Nieman K, Akasaka T, Berman DS, Raff GL, Hurwitz Koweek LM, Pontone G, Kawasaki T, Rønnow Sand NP, Jensen JM, Amano T, Poon M, Øvrehus KA, Sonck J, Rabbat MG, Mullen S, De Bruyne B, Rogers C, Matsuo H, Bax JJ, Leipsic J.
J Cardiovasc Comput Tomogr. 2021 Mar-Apr;15(2):121-128. doi: 10.1016/j.jcct.2020.08.006. |
|
|
| Development of the Elective Outpatient Percutaneous Coronary Intervention Episode-Based Cost Measure. |
Sandhu AT, Do R, Lam J, Blankenship J, Van Decker W, Rich J, Gonzalez O, Wu X, Pershing S, Lin E, MaCurdy TE, Bhattacharya J, Nagavarapu S; Elective Outpatient PCI Cost Measure Writing Group.
Circ Cardiovasc Qual Outcomes. 2021 Mar;14(3):e006461. doi: 10.1161/CIRCOUTCOMES.119.006461. |
|
|
|
Cost-effectiveness of Canakinumab for Prevention of Recurrent Cardiovascular Events.
|
Sehested TSG, Bjerre J, Ku S, Chang A, Jahansouz A, Owens DK, Hlatky MA, Goldhaber-Fiebert JD.
JAMA Cardiol. 2019 Feb 1;4(2):128-135. doi: 10.1001/jamacardio.2018.4566.
Interventions to Reduce Ethnic and Racial Disparities in Dyslipidemia Management. Chang A, Abou-Arraj N, Rodriguez F. Current Treatment Options in Cardiovascular Medicine, 2019. [Preprint] |
|
|
|
|
|
|
